Reviewing the controversy surrounding pre-treatment with P2Y(12) inhibitors in acute coronary syndrome patients

被引:11
作者
Capodanno, Davide [1 ]
Angiolillo, Dominick J. [2 ]
机构
[1] Univ Catania, Ferrarotto Hosp, Catania, Italy
[2] Univ Florida, Coll Med Jacksonville, 655 West 8th St, Jacksonville, FL 32209 USA
关键词
Pretreatment; loading dose; prasugrel; ticagrelor; preloading;
D O I
10.1586/14779072.2016.1164035
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pretreatment with oral P2Y(12) inhibitors occurs each time clopidogrel, prasugrel, ticagrelor are given to patients with suspected coronary artery disease before definition of the coronary anatomy. In acute coronary syndromes, the practice of administering oral P2Y(12) inhibitors upstream has been the object of significant controversy in recent years, following the publication of two trials of pretreatment in non-ST-segment elevation acute coronary syndromes and ST-segment elevation myocardial infarction, respectively. The introduction in the market of cangrelor - the first intravenous P2Y(12) inhibitor - represents a new opportunity but also a new challenge for clinicians. This article reviews current recommendations and supporting evidence surrounding pretreatment with oral and intravenous P2Y(12) inhibitors in patients with acute coronary syndromes.
引用
收藏
页码:811 / 820
页数:10
相关论文
共 52 条
[1]  
Amsterdam EA, 2014, CIRCULATION, V130, P2354, DOI 10.1161/CIR.0000000000000133
[2]   High clopidogrel loading dose during coronary stenting:: effects on drug response and interindividual variability [J].
Angiolillo, DJ ;
Fernández-Ortiz, A ;
Bernardo, E ;
Ramírez, C ;
Sabaté, M ;
Bañuelos, C ;
Hernández-Antolín, R ;
Escaned, J ;
Moreno, R ;
Alfonso, F ;
Macaya, C .
EUROPEAN HEART JOURNAL, 2004, 25 (21) :1903-1910
[3]   Effects of Ticagrelor Versus Clopidogrel in Troponin-Negative Patients With Low-Risk ACS Undergoing Ad Hoc PCI [J].
Angiolillo, Dominick J. ;
Franchi, Francesco ;
Waksman, Ron ;
Sweeny, Joseph M. ;
Raveendran, Ganesh ;
Teng, Renli ;
Zhao, Yonggang ;
Carlson, Glenn ;
Khan, Naeem ;
Mehran, Roxana .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (06) :603-613
[4]   Impact of cangrelor overdosing on bleeding complications in patients undergoing percutaneous coronary intervention: insights from the CHAMPION trials [J].
Angiolillo, Dominick J. ;
Bhatt, Deepak L. ;
Steg, Ph. Gabriel ;
Stone, Gregg W. ;
White, Harvey D. ;
Gibson, C. Michael ;
Hamm, Christian W. ;
Price, Matthew J. ;
Prats, Jayne ;
Liu, Tiepu ;
Mahaffey, Kenneth W. ;
Harrington, Robert A. .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2015, 40 (03) :317-322
[5]   Pharmacodynamic effects of cangrelor and clopidogrel: the platelet function substudy from the cangrelor versus standard therapy to achieve optimal management of platelet inhibition (CHAMPION) trials [J].
Angiolillo, Dominick J. ;
Schneider, David J. ;
Bhatt, Deepak L. ;
French, William J. ;
Price, Matthew J. ;
Saucedo, Jorge F. ;
Shaburishvili, Tamaz ;
Huber, Kurt ;
Prats, Jayne ;
Liu, Tiepu ;
Harrington, Robert A. ;
Becker, Richard C. .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2012, 34 (01) :44-55
[6]   Bridging Antiplatelet Therapy With Cangrelor in Patients Undergoing Cardiac Surgery A Randomized Controlled Trial [J].
Angiolillo, Dominick J. ;
Firstenberg, Michael S. ;
Price, Matthew J. ;
Tummala, Pradyumna E. ;
Hutyra, Martin ;
Welsby, Ian J. ;
Voeltz, Michele D. ;
Chandna, Harish ;
Ramaiah, Chandrashekhar ;
Brtko, Miroslav ;
Cannon, Louis ;
Dyke, Cornelius ;
Liu, Tiepu ;
Montalescot, Gilles ;
Manoukian, Steven V. ;
Prats, Jayne ;
Topol, Eric J. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (03) :265-274
[7]   Reappraisal of thienopyridine pretreatment in patients with non-ST elevation acute coronary syndrome: a systematic review and meta-analysis [J].
Bellemain-Appaix, Anne ;
Kerneis, Mathieu ;
O'Connor, Stephen A. ;
Silvain, Johanne ;
Cucherat, Michel ;
Beygui, Farzin ;
Barthelemy, Olivier ;
Collet, Jean-Philippe ;
Jacq, Laurent ;
Bernasconi, Francois ;
Montalescot, Gilles .
BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
[8]   Association of Clopidogrel Pretreatment With Mortality, Cardiovascular Events, and Major Bleeding Among Patients Undergoing Percutaneous Coronary Intervention A Systematic Review and Meta-analysis [J].
Bellemain-Appaix, Anne ;
O'Connor, Stephen A. ;
Silvain, Johanne ;
Cucherat, Michel ;
Beygui, Farzin ;
Barthelemy, Olivier ;
Collet, Jean-Philippe ;
Jacq, Laurent ;
Bernasconi, Francois ;
Montalescot, Gilles .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (23) :2507-2516
[9]   Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events [J].
Bhatt, Deepak L. ;
Stone, Gregg W. ;
Mahaffey, Kenneth W. ;
Gibson, C. Michael ;
Steg, P. Gabriel ;
Hamm, Christian W. ;
Price, Matthew J. ;
Leonardi, Sergio ;
Gallup, Dianne ;
Bramucci, Ezio ;
Radke, Peter W. ;
Widimsky, Petr ;
Tousek, Frantisek ;
Tauth, Jeffrey ;
Spriggs, Douglas ;
McLaurin, Brent T. ;
Angiolillo, Dominick J. ;
Genereux, Philippe ;
Liu, Tiepu ;
Prats, Jayne ;
Todd, Meredith ;
Skerjanec, Simona ;
White, Harvey D. ;
Harrington, Robert A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (14) :1303-1313
[10]   Intravenous Platelet Blockade with Cangrelor during PCI. [J].
Bhatt, Deepak L. ;
Lincoff, A. Michael ;
Gibson, C. Michael ;
Stone, Gregg W. ;
McNulty, Steven ;
Montalescot, Gilles ;
Kleiman, Neal S. ;
Goodman, Shaun G. ;
White, Harvey D. ;
Mahaffey, Kenneth W. ;
Pollack, Charles V., Jr. ;
Manoukian, Steven V. ;
Widimsky, Petr ;
Chew, Derek P. ;
Cura, Fernando ;
Manukov, Ivan ;
Tousek, Frantisek ;
Jafar, M. Zubair ;
Arneja, Jaspal ;
Skerjanec, Simona ;
Harrington, Robert A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (24) :2330-2341